- Home
- SND vs UNCY Comparison
SND vs UNCY Comparison
Compare SND & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- UNCY
- Stock Information
- Founded
- SND 2011
- UNCY 2016
- Country
- SND United States
- UNCY United States
- Employees
- SND N/A
- UNCY N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- UNCY Health Care
- Exchange
- SND Nasdaq
- UNCY Nasdaq
- Market Cap
- SND 75.7M
- UNCY 74.2M
- IPO Year
- SND 2016
- UNCY 2021
- Fundamental
- Price
- SND $2.00
- UNCY $4.04
- Analyst Decision
- SND
- UNCY Strong Buy
- Analyst Count
- SND 0
- UNCY 5
- Target Price
- SND N/A
- UNCY $55.20
- AVG Volume (30 Days)
- SND 76.9K
- UNCY 425.0K
- Earning Date
- SND 11-11-2025
- UNCY 11-12-2025
- Dividend Yield
- SND 4.97%
- UNCY N/A
- EPS Growth
- SND N/A
- UNCY N/A
- EPS
- SND 0.02
- UNCY N/A
- Revenue
- SND $305,848,000.00
- UNCY N/A
- Revenue This Year
- SND N/A
- UNCY N/A
- Revenue Next Year
- SND N/A
- UNCY $4,481.14
- P/E Ratio
- SND $95.94
- UNCY N/A
- Revenue Growth
- SND 3.43
- UNCY N/A
- 52 Week Low
- SND $1.76
- UNCY $3.40
- 52 Week High
- SND $2.80
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- SND 57.94
- UNCY 41.84
- Support Level
- SND $1.88
- UNCY $3.80
- Resistance Level
- SND $1.99
- UNCY $4.21
- Average True Range (ATR)
- SND 0.06
- UNCY 0.20
- MACD
- SND 0.01
- UNCY -0.01
- Stochastic Oscillator
- SND 85.71
- UNCY 38.10
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.